cbd oil for metastic colorectal cancer


Colorectal cancer (CRC) is the third most common cancer in both men than women. The standard treatment for CRC is chemotherapy after resection of the colon by surgery. How chemotherapy drugs come used schemes such as FOLFOX (5-fluorouracil + leucovorin + oxaliplatin), XELOX (capecitabine + oxaliplatin), or FOLFIRI (5FU / leuc + irinotecan) in combination with bevacizumab, an antiangiogenic agent. Unfortunately, repeated and long-term administration of these molecules it induces in more than 40% of patients what is defined drug resistance.

In a study published in the journal Cancer in 2019, it was assessed CBD activity in combination with the drug traditional Oxaliplatin. The results clearly showed that CBD modulated the phosphorylation of an important enzyme such as NOS3 which leads to the formation of nitric oxide (NO) in the cell. In patients with colon cancer and beyond, who develop drug resistance, NOS3 and nitric oxide levels are increased. Cannabidiol during testing, he has reduced the phosphorylation of NOS3 and therefore the contribution of NO and simultaneously stimulated the production of reactive species oxygen (ROS), responsible for the forced induction towards the programmed death of the tumor cell. These phenomena triggered by the use of CBD in conjunction with standard therapy, have clearly improved the sensitivity of cells to drugs by reducing by very much the phenomenon of resistance. According to the researchers, therefore, the combination of CBD with classic drugs can represent certainly an excellent and most effective therapy against colorectal cancers.

In the study (Aviello et al.) published in 2012 in the Journal of Molecular Medicine, CBD has been shown to exert a significant antiproliferative effect in two colorectal cancer cell lines (Caco-2 and HCT116). As emerged in other studies, the anticancer action of CBD seems to be related to the direct regulation of the activity of some proteases such as Caspase-3, which has also proved crucial in the triggering of apoptosis and hence the death of the cancer cell. Treatment with only 1 mg / kg of CBD significantly reduced aberrant crypts, polyps and tumors, suggesting for the umpteenth time the potential of Cannabidiol in blocking the vitality and proliferation of malignant cells. Several other studies in recent years have focused on the effects of CBD in the intestine. Among the many capacities, CBD is in fact able to reduce inflammation intestinal process directly linked to the beginning of colorectal cancer.

In a recent study it was reported that in a colon cancer model, CBD was also able to reduce liver metastases in vivo, antagonizing G Coupled Receptor-55 (GPR55) proteins, a known receptor involved in the appearance of metastasis, cell migration and adhesion (Kargl et al., 2016).

Colon cancer remains a widespread and often difficult to treat disease to date. New, more effective therapeutic strategies are therefore needed, and above all with fewer side effects. For this reason, given the scientific evidence, CBD in the coming years could certainly represent a first-line therapy in the fight against Colon Cancer.

What Does Research Say Medical Marijuana Does For Colorectal Cancer?

If there is one common theme in all of the literature and scientific papers, it is that cannabis and cannabinoids enhance the benefits of conventional treatment for side effect management. For cancer patients, this is most notable in chemotherapy-induced nausea and vomiting as well as pain management.

In an article published in the Journal of the American Medical Association Oncology this year, authors reviewed the literature surrounding the treatment of cancer with cannabis. While the majority of the data came from animal trials, results were positive. For example, tetrahydrocannabinol (THC) slowed lung cancer tumor growth in mice. Although the information is promising in animals, further research in human clinical trials is needed.

What the clinical trials are saying:

While there have been a few clinical trials in humans studying the use of cannabis as a cancer treatment, the results are either inconclusive or still pending. Some of these clinical trials include:

A clinical trial in humans with malignant brain cancer (glioblastoma multiforme aka GBM) showed tumor shrinkage in two out of nine patients when THC was administered directly into the tumor. Unfortunately, even though the tumors shrunk, the patients did not live longer.

Two other clinical trials in Israel are studying the treatment of GBM with cannabis in patients who have failed all other treatments.

Another clinical trial in Israel is studying cannabinol as a single agent in patients with solid tumors who have failed all other therapies.

Now that you have the research…

Points to consider when deciding whether to take medical marijuana:

Impact on treatment: Regardless of whether or not marijuana is legal in your state, it is important to tell your doctor if and how you use marijuana, either recreationally or medically, and the frequency of your use. Marijuana interferes with the metabolism of many drugs, including chemotherapeutic agents and herbal supplements. Marijuana is metabolized in the liver as are many chemotherapy agents.

Side effects: Evaluate whether the side effects and adverse effects of medical marijuana outweigh the perceived benefits. Medical marijuana, along with many FDA-approved drugs and alcohol, all have adverse effects. It is important to weigh the pros and cons.

Not a cure-all: If you choose to use medical marijuana for chemotherapy-induced nausea and vomiting, it is best to use it along with standard treatments.

False hope: Cannabis in any form, including oil, does not cure cancer. Additionally, there is no evidence that it prevents cancer. The oil can actually be toxic due to the high concentrations of chemicals. If you are going to use medical marijuana, do not think of it as a cure-all.

No quality control: Just because it is natural does not mean it is safe. Medical marijuana is not guaranteed to have the compounds that may be specified because there is no regulatory body monitoring medical marijuana manufacturing.

Variance by state: The list of acceptable conditions and the amount of medical marijuana a person is allowed to have and/or grow depends on the state in which you live. Make sure you know your state’s laws.

Addiction: It’s better not to use medical marijuana if you have a history of substance abuse. Approximately nine percent of adults who use marijuana become addicted.

If you or someone you love is considering medical marijuana, do your research, look at the references we provide, talk with others, and speak with your doctor. To get an in-depth understanding or answers to other questions about medical marijuana, watch the What You Need to Know About Medical Marijuana & CRC webinar.

The Colon Cancer Alliance does not endorse or recommend any specific treatment or screening method for colorectal cancer; rather we serve as a source of scientifically accurate medical information to help empower patients and their caregivers to make informed decisions in consultation with their health professionals.

Don’t forget, the Colon Cancer Alliance serves as a source of information about colon health. If you have additional questions about colon cancer screening or are in need of support, please contact our free Helpline at (877) 422-2030. We’re here to help.